Cardinal Health (CAH) reported fiscal first-quarter earnings per share of 54 cents, surpassing the Zacks Consensus Estimate of 43 cents and the year-ago earnings of 47 cents.

Sales

Total sales in the reported quarter increased 6% year over year to $24.8 billion. Growth was witnessed across all the business segments.

Pharmaceutical segment revenues increased 5% year over year to $22.6 billion. Growth was primarily due to higher sales to existing pharmaceutical distribution customers. Sales to bulk customers increased 6% year over year to $11.3 billion. Sales to non-bulk customers increased 5% year over year to $11.2 billion.

Medical segment revenues increased 10% year over year to $2.2 billion. Growth can be primarily attributed to higher sales to existing customers. In addition, the CareFusion Corp. (CFN) spin-off has resulted in immediate revenue recognition from international sales to CareFusion.

Margins

Cardinal Health registered a minimal contraction in margins. Gross margin declined 10 basis points (bps) year over year to 3.7%. Distribution, selling, general and administrative expenses as a percentage of sales declined 10 bps year over year to 2.4%. Operating margin declined 20 bps year over year to 1.0%.

Balance Sheet & Cash Flow

Cardinal Health ended the reported quarter with cash and cash equivalents of roughly $1.6 billion, an increase of 30% sequentially. Cash flow from operations was $0.4 billion.

Guidance

Cardinal Health expects earnings per share to be at the higher end of its prior guidance of $1.90 to $2.

Cardinal Health is one of the largest global healthcare companies that helps pharmacies, hospitals and ambulatory care sites to focus on low-cost patient care. The company is also a leading manufacturer of medical and surgical products. The company recently completed the spin-off of its Clinical and Medical Products business to form a subsidiary, CareFusion Corporation. The spin-off was completed through a pro rata distribution of roughly 81% of CareFusion’s common stock.

Zacks Investment Research
View original at: Zacks.com News Feed

1. (WMGI) Wright Medical Group Eclipses Consensus EstimatesWright Medical Group, Inc. (WMGI) reported third-quarter earnings per share of 19 cents, surpassing the...
2. (CAH) Cardinal Health Completes Spin-Off – Analyst BlogCardinal Health, Inc. (CAH) has completed the spin-off of its Clinical and Medical Products business...
3. (CAH) Cardinal Health Makes Buyback OfferCardinal Health, Inc. (CAH) has offered to buy back $1.2 billion of its long-term debt...
4. (CAH) Cardinal Health Sees Positive Results for Skin Preparation DrugCardinal Health Inc. (CAH) announced that the use of the preoperative skin preparation, ChloraPrep, is...
5. (CAH) Cardinal’s Spin-off to be Added to S&P 500 IndexCardinal Health Inc. (CAH) announced that its spin-off subsidiary, CareFusion Corp., will be included in...
6. (CAH) Cardinal Health, Inc.: Stock of the Dayby David Fessler, Advisory Panelist, Investment U When we think of industrial suppliers, W.W. Grainger...

Search Posts by Tag: CAH | Cardinal Health | Drugs Wholesale | Services

RSS Feeds by Tag: CAH | Cardinal Health | Drugs Wholesale | Services |

Other Posts by: vitalstocks | RSS Feed for this author